Understanding rhabdomyolysis induced acute kidney injury in patients with COVID-19

doi:10.5501/wjv.v13.i4.101065

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2615)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

1521

Sum=1615

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

262

Download

608

Sum=870

Dec 25, 2024 (publication date) through Feb 18, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Virol. Dec 25, 2024; 13(4): 101065
Published online Dec 25, 2024. doi: 10.5501/wjv.v13.i4.101065

Understanding rhabdomyolysis induced acute kidney injury in patients with COVID-19

Alexander Ikanović, Karan Varshney

Alexander Ikanović, Karan Varshney, School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia

Karan Varshney, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia

Author contributions: Ikanović A and Varshney K were responsible for conceptualization, analysis, writing original draft preparation, writing review and editing; Varshney K was responsible for supervision; all authors have read and agreed to the published version of the manuscript.

Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.

Corresponding author: Karan Varshney, Researcher, School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, VIC 3216, Australia. karan.varshney@monash.edu

Received: September 3, 2024
Revised: September 25, 2024
Accepted: October 8, 2024
Published online: December 25, 2024
Processing time: 44 Days and 20.3 Hours

Core Tip

Core Tip: The article published in the recent issue of the World Journal of Virology (2024) has shown that patients with rhabdomyolysis induced acute kidney injury (RIAKI) as a complication of coronavirus disease 2019 (COVID-19) infection tend to show elevated levels of specific biomarkers. Additionally, patients with RIAKI in COVID-19 infection have worse outcomes compared to patients who have acute kidney injury due to other causes in COVID-19 infection. To improve overall outcomes, there is a need to better understand the mechanism for RIAKI development in COVID-19, and to create evidence-based treatment protocols for this condition. To determine which approaches are most effective, more research on the outcomes for patients with differing treatment regimens is required.